Back to all news

Deep Learning on PSMA-PET Scans Predicts Survival in Prostate Cancer

AuntMinnieIndustry

Deep learning models applied to PSMA-PET scans outperform existing tools in predicting two-year survival for metastatic prostate cancer.

Key Details

  • 1Retrospective analysis of 486 PSMA-PET scans for metastatic prostate cancer patients from 2017-2025.
  • 2Two models developed: an imaging-only model and a fusion model combining imaging and clinical variables.
  • 3Fusion model achieved an AUC of 0.86, imaging model 0.82; both outperformed six established risk tools (AUC 0.43 to 0.65).
  • 4Fusion model identified survival subgroups: 93% versus 43% two-year survival.
  • 5Performance was consistent across radiotracers, treatment history, and metastatic burden.
  • 6Researchers suggest prospective validation could enable personalized treatment selection.

Why It Matters

This demonstrates the potential of AI-driven PSMA-PET image analysis to enhance risk stratification and guide treatment for metastatic prostate cancer patients, surpassing conventional tools. Its adoption could personalize care and improve patient outcomes in clinical practice.

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.